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Evidence that processed small dsRNAs may mediate sequence-
specific mRNA degradation during RNAi in Drosophila embryos
Dun Yang*, Hong Lu and James W. Erickson
Background: RNA interference (RNAi) is a phenomenon in which introduced
double-stranded RNAs (dsRNAs) silence gene expression through specific
degradation of their cognate mRNAs. Recent analyses in vitro suggest that
dsRNAs may be copied, or converted, into 21–23 nucleotide (nt) guide RNAs
that direct the nucleases responsible for RNAi to their homologous mRNA
targets. Such small RNAs are also associated with gene silencing in plants.
Results: We developed a quantitative single-embryo assay to examine the
mechanism of RNAi in vivo. We found that dsRNA rapidly induced mRNA
degradation. A fraction of dsRNAs were converted into 21–23 nt RNAs, and
their time of appearance and persistence correlated precisely with inhibition of
expression. The strength of RNAi increased disproportionately with increasing
dsRNA length, but an 80 bp dsRNA was capable of effective gene silencing.
RNAi was saturated at low dsRNA concentration and inhibited by excess
unrelated dsRNA. The antisense strand of the dsRNA determined target
specificity, and excess complementary sense or antisense single-stranded
RNAs (ssRNAs) competed with the RNAi reaction.
Conclusions: Processed dsRNAs can act directly to mediate RNAi, with the
antisense strand determining mRNA target specificity. The involvement of
21–23 nt RNAs is supported by the kinetics of the processing reaction and the
observed size dependence. RNAi depends on a limiting factor, possibly the
nuclease that generates the 21–23mer species. The active moiety appears to
contain both sense and antisense RNA strands.
Background
In many eukaryotic cells, when double-stranded RNA
(dsRNA) complementary to an endogenous gene is intro-
duced, it can specifically and effectively inhibit expression
of its cognate gene [1–4]. This curious phenomenon of
RNA interference (RNAi) is thought to be related to
normal host defenses against viruses and to restrict the move-
ment of transposable elements [1,2,5–8]. Because of its effi-
cacy, specificity and generality, RNAi has been adapted for
genetic analysis in organisms spanning the breadth of eukary-
otic phyla. In plants, dsRNAs can silence genes before RNA
synthesis, by DNA modification, as well as after transcription
by reducing steady-state mRNA levels (reviewed in [9]). In
animals, dsRNA appears only to induce post-transcriptional
gene silencing (PTGS), as dsRNA reduces mRNA levels
without causing DNA alterations, and the inhibitory effect
can be inherited in the absence of the cognate gene [10,11].
The most remarkable feature of RNAi is its specificity;
dsRNA inhibits expression of the gene that encodes the
dsRNA without affecting the expression of unrelated
sequences [1,10,12,13]. The available evidence indicates
that dsRNA targets its cognate mRNA species for degrada-
tion. Specifically, dsRNAs corresponding to exon sequences
are active in RNAi, whereas those corresponding to introns
are not [1].  In addition, exonic dsRNAs have been found to
reduce the levels of mRNAs in vivo [1,12–14] while having
little or no effect on the levels of pre-mRNA species [10,13].
The sequence specificity of RNAi implies that base-
pairing interactions between dsRNA, or a product of the
dsRNA, and the mRNA are likely to mediate target speci-
ficity. Two recent papers addressing the mechanism of
RNAi in vitro offer support for this idea, and suggest that
small 21–23 nucleotide (nt) RNAs may be the agents
responsible for dsRNA-induced gene silencing [14,15].
These small RNAs have been found in extracts prepared
from cultured Drosophila cells [14], and can be produced in
embryo lysates treated with dsRNA [15]. Importantly,
21–23 nt RNAs are associated with dsRNA-induced nucle-
ases capable of carrying out sequence-specific mRNA
degradation in vitro [14]. Similar sized RNAs have also
been detected in plants, where their abundance is corre-
lated with the extent of PTGS [16], raising the possibility
that 21–23 nt RNAs are a universal feature of PTGS. 
The amplification inherent in the processing of large
dsRNA into smaller species could also explain the finding
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that only a few molecules of dsRNA are required to inhibit
expression of mRNA species present in far higher concen-
trations [1,2,10,12]. The ability of dsRNA to act sub-stoi-
chiometrically could be further enhanced if the small
RNA-containing nucleases recycle, or are regenerated,
after interaction with their targets [14,15,17]. It is also pos-
sible that dsRNA, or processed 21–23mers, could serve as
templates for an RNA-dependent RNA polymerase
(RdRP), with new RNA synthesis accounting for signal
amplification and for the long-lived RNAi effects seen in
C. elegans and plants [9,11]. Support for indirect amplifica-
tion comes from the discoveries that the Neurospora crassa
qde-1, Caenorhabditis elegans ego-1 and Arabidopsis thaliana
SDE1/SGS2 genes, which function in PTGS, encode
homologs of plant and viral RdRPs [18–21]. 
Despite the considerable appeal and explanatory power of
models invoking small RNAs, there is, as yet, little evi-
dence that the 21–23 nt RNAs identified in vitro mediate
RNAi in vivo. To study the mechanisms underlying RNAi,
we have developed a quantitative in vivo RNAi assay that
exploits the ability of single Drosophila embryos to express
luciferase from injected plasmid or mRNA templates. The
assay recapitulates the properties of dsRNA-directed inhi-
bition of endogenous genes and has allowed us to quantify
important parameters of the RNAi reaction including its
dsRNA concentration and size dependence. We have found
that RNAi-induced mRNA degradation can occur in the
apparent absence of RNA synthesis and is strictly correlated
with the production of processed 21–23 nt RNAs. Our find-
ings agree with those obtained in vitro [14,15], and provide
strong support for the hypothesis that large dsRNAs are
rapidly processed into 21–23 nt guide RNAs that provide
the sequence specificity of the RNAi reaction. On the basis
of the ability of excess sense or antisense RNAs to inhibit
RNAi, and the resistance of purified 21–23mer species to
RNase, we suggest that the nucleases responsible for RNAi
contain both strands of the processed dsRNA.
Results
Our quantitative assay to study RNAi in Drosophila uses
plasmid DNA or mRNA templates encoding two unrelated
luciferase reporter genes. These were co-injected with
dsRNA molecules into early embryos; dsRNA of one
luciferase gene was used to inhibit expression from the
cognate template, with the other luciferase serving as an
internal control. To express the luciferase genes from DNA
templates, we injected plasmid fusions between the early
acting, uniformly expressed sisA and sisB promoters [22],
and the luciferase genes F-luc from firefly, and R-luc from
Renilla reniformis (sea pansy). For the mRNA experiments,
we injected in vitro synthesized capped and polyadenylated
F-luc and R-luc mRNAs (Figure 1). Control embryos col-
lected 3 hours after injection (during gastrulation) possessed
high luciferase activity, and the ratio of the two luciferase
activities (R-Luc:F-Luc) was reproducible. Accordingly,
dsRNA function was assessed by measuring its effect on
the ratio of the two luciferase activities in individual
embryos that developed normally 3 hours after injection.
Specific inhibition by dsRNA of expression from cognate
plasmid or mRNA templates
To test whether dsRNAs can inhibit expression from
plasmid templates, we co-injected ~600 bp dsRNA mol-
ecules and R-luc and F-luc reporters into embryos. We
found that dsR-602 RNA (see Figure 1) was a potent (265-
fold) inhibitor of R-luc expression and that dsF-600 RNA
(see Figure 1) was an effective (160-fold) inhibitor of F-luc
expression (Figure 2a). This reciprocal effect on the
R-Luc:F-Luc ratio indicates that the dsRNAs acted in a
sequence-specific manner without affecting expression
from the non-complementary control templates. The speci-
ficity of inhibition was further supported by the observa-
tion that neither polyI–polyC, nor unrelated dsRNAs from
the endogenous Sxl or Escherichia coli lacZ genes affected
the ratio of the two luciferase activities (Figure 2a, and
data not shown).
The dsR-602 and dsF-600 RNAs exhibited a 40–50-fold
inhibition of luciferase activity from in vitro synthesized
mRNAs, suggesting that dsRNA is also an effective and
specific silencer of mRNA templates (Figure 2b). Because
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Figure 1
Reporter plasmids, mRNAs and dsRNAs. The R-luc and F-luc reporter
genes used to produce mRNA in vivo and in vitro, and dsRNA in vitro
are shown. In vivo, mRNAs initiated from sisA or sisB promoters (P)
and ended at the SV40 poly(A) sequence. In vitro, m7G capped
mRNAs initiated at the phage T7 promoter and terminated with a run of
30 A residues. The locations and sizes of dsRNAs and single-stranded
RNAs (ssRNAs) are indicated by the double lines and numbers on the
right. The RNAs are designated by their size and whether they are
derived from R-luc or F-luc; for example, dsR-602 RNA refers to the
602 bp dsRNA derived from R-luc, snR-280 is the 280 nt sense strand
of R-280, and asR-280, the antisense strand. For RNAs with intron
and exon sequences, the length of exon sequences are shown in
parentheses. The position of relevant single nucleotide differences
between F-luc sequences in the pGL2 and pGL3 vectors are indicated
at expanded scale.
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control experiments showed that ~30% of total luciferase
activity was produced within 20 minutes of mRNA injec-
tion (data not shown), we initially injected the dsRNAs
first, followed 20 minutes later by the mRNA templates to
ensure efficient RNAi. Later, we found that co-injection
of mRNA and dsRNA produced a comparable degree of
inhibition, suggesting that injected dsRNA acts rapidly to
silence expression in vivo (Figure 2c).
Concentration dependence of dsRNA inhibition
To characterize further the RNAi reaction, we examined its
dependence on dsRNA concentration. We found that the
~600 bp dsRNAs effectively inhibited expression from
plasmid and mRNA templates when the injection buffer
contained ≥ 0.1 µM dsRNA (Figure 2d,e). There was a sharp
transition from no effect, to fully inhibiting, over a narrow
range of concentrations below 0.1 µM (Figure 2d,e). Assum-
ing 0.1 nl injection, and 7.3 nl embryo volumes, we esti-
mated that the saturating in vivo concentration of dsRNA
was ~1.3 nM. This is less than the ~25 nM concentration
required to completely silence endogenous genes in
Drosophila embryos, but greater than the minimal ~0.4 nM
concentration at which inhibition has been observed [12,23].
To confirm that dsRNA, and not trace ssRNA contaminants
were responsible for inhibition, we compared the inhibitory
ability of dsRNA with that of the corresponding sense and
antisense RNAs. We found that sense-strand RNAs were
incapable of inhibiting R-Luc or F-Luc activity even
when injected in 30–60-fold excess of the minimum satu-
rating dsRNA concentrations (Figure 2d,e). High concen-
trations of antisense R-602 RNA did, however, inhibit
expression from plasmid templates (Figure 2d). We do not
know whether this reflects conventional antisense inhibi-
tion of R-luc expression, the formation of dsRNA in vivo,
or low-level contamination of the antisense R-602 sample
with dsRNA. Regardless of mechanism, the much greater
potency of dsRNA indicates that the inhibitory effects
were due primarily to dsRNA.
Dependence of inhibitory activity on dsRNA size
Short dsRNA molecules have been reported to be less
potent inhibitors than long dsRNAs. Nevertheless, RNAi
effects have been observed with dsRNAs as small as
190 bp in C. elegans and 59 bp in Trypanosoma brucei
[13,24]. To determine the relationship between dsRNA
length and RNAi efficiency in Drosophila, we synthesized
double-stranded R-luc RNAs of various sizes (Figure 1)
and assayed their effects at saturating dsRNA concentra-
tions. We found a linear relationship between dsRNA
length and the log value of inhibition for dsRNAs
between ~80 and 900 bp (Figure 3a). While confirming
previous qualitative assessments that large dsRNAs are
more potent than small ones, the log-linear relationship
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Figure 2
Specificity of RNAi and its dependence on
dsRNA concentration. (a,b) Effect of
dsRNA on R-luc and F-luc expression from
(a) plasmid or (b) mRNA templates. Injection
buffers contained templates and dsR-602 or
dsF-600 RNAs at 0.6 µM, or dsSxl-490 RNA
at 6.0 µM (1.9 µg/µl), or polyI–polyC at
2 µg/µl. In (a), DNAs and dsRNAs were
co-injected; in (b), dsRNAs were injected first,
followed by mRNAs after 20 min. A dash
indicates that only the reporter was injected.
(c) Effect of dsRNA pre-injection on mRNA
expression. The protocol was as in (b), except
that dsR-602 RNA was pre-injected (–10 or
–30 min) or co-injected with mRNA templates.
(d,e) Concentration dependence of sense,
antisense, and double-stranded R-602 and
F-600 RNAs on luciferase expression from
(d) co-injected DNA or (e) sequentially
injected (–20 min) mRNA templates. The
horizontal axes indicate RNA concentration in
the injection buffer. Unless otherwise
indicated, data in all figures are expressed
as the mean ratio of luciferase activities
(R-Luc:F-Luc) 3 h after template injection.
Seven to 22 embryos were sampled for each
point. Error bars equal ± 1 SD. Injection
buffers contained plasmids at 70 nM (R-luc)
and 7.0 nM (F-luc), or mRNAs at 2.0 µM.
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indicates that dsRNAs become disproportionately more
effective with increasing size.
Rapid induction of degradation of cognate mRNAs by
dsRNA in vivo
The available evidence suggests that RNAi works by target-
ing mature mRNA species for degradation [1,10,13–15,23].
Consistent with the specificity for mRNA, we found that
dsRNAs containing the 137 bp R-luc intron and up to
23 bp of flanking exon sequence failed to inhibit R-luc
expression (Figure 3a). To determine whether dsRNA
induces the degradation of target mRNA sequences in
Drosophila embryos, we examined the fate of R-luc and
F-luc mRNAs injected in the presence or absence of
dsRNA. Using a northern blot assay, we found that R-luc
and F-luc mRNA decay was greatly accelerated by
co-injection of the cognate dsRNAs (Figure 3b). Indeed,
most dsRNA-induced degradation occurred within the
~10 minute period between mRNA injection and initial
sampling, as the relative R-luc and F-luc mRNA levels
were depressed by 10–30-fold in the first time points we
could analyze (Figure 3b). As expected, unrelated dsRNA
was without effect (data not shown).
dsRNAs are processed to 21–23 base species in vivo
Recently, Zamore et al. [15] reported that dsRNAs are
processed to small ~21–23 nt sequences in Drosophila
embryo extracts. Similar small RNAs are associated with a
dsRNA-dependent nuclease purified from cultured cells
[14], making it likely that such RNAs serve as the speci-
ficity determinants in the RNAi reaction, an inference
supported by the pattern of target mRNA degradation
in vitro [15]. To determine whether dsRNAs could be
processed quickly enough to account for the rapid inhibi-
tion we observed, we injected 32P-labeled dsR-800 RNA
into embryos and monitored for the appearance of small
32P-labeled RNAs by polyacrylamide gel electrophoresis.
Injected dsRNAs were processed into ~21–23 nt species
within 10 minutes, and the small RNAs persisted through-
out the 3 hour assay (Figure 4). As was seen in vitro [15],
21–23 nt RNAs were formed in the absence of target
ssRNAs, when either of the two strands were labeled, or
when dsRNAs were treated with RNase T1 before injec-
tion (data not shown), demonstrating that the 21–23 nt
RNAs were the products of dsRNA cleavage.
New RNA synthesis seems not to be required for RNAi
In Neurospora, C. elegans and Arabidopsis, RdRP homologs
are important for aspects of PTGS [18–21]. This raises
the possibility that RNAi could be mediated indirectly,
by transcribed products of dsRNA molecules, rather than
directly by the full-length or processed dsRNAs. An
experiment to distinguish between these possibilities
is to test RNAi activity under conditions where RNA
synthesis should not occur. We used the RNA chain-ter-
minating substrate cordycepin (3′deoxyATP) to inhibit
RNA synthesis, as in principle, it can block all RNA chain
elongation. We first confirmed that cordycepin blocked
embryonic development and expression of R-luc plasmid
DNA without affecting translation of co-injected F-luc
mRNA (data not shown). We then compared the ability
of sub-stoichiometric amounts of dsF-600 and dsR-602
RNAs to inhibit expression from F-luc and R-luc mRNAs
in the presence and absence of a cordycepin concentra-
tion approximately twice that of the ATP pool. We found
that RNAi activity was unaffected by the inhibitor:
dsF-600 RNA strongly reduced F-luc expression with or
without cordycepin, and dsR-602 caused a 30–40-fold
decrease in R-luc expression under both conditions
(Figure 5a).
1194 Current Biology Vol 10 No 19
Figure 3
(a) Dependence of RNAi activity on the
length of the dsRNA. This was assessed by
injection of different sized dsRNAs; dsR-137i
and dsR-160 (23) RNAs were injected at
6.0 µM; dsR-80, dsR-217 (80), dsR-145,
dsR-300 (163), dsR-291, dsR-602 and
dsR-928 RNAs were injected at 0.6 µM.
The saturating concentration for dsR-80 and
dsR-145 RNAs was confirmed to be
0.15 µM. (b) Double-stranded RNA induces
rapid degradation of cognate mRNA species.
Northern blot analysis of F-luc and R-luc
mRNA levels in the presence or absence of
dsRNA. F-luc or R-luc mRNAs (2.0 µM) were
injected 20 min after dsF-562 or dsR-291
dsRNAs (0.4 µM) and sampled for mRNA
content at times thereafter. Each time point
represents the pooled contents of 20
embryos. F-luc and R-Luc northern blots
were probed with 32P-labeled, antisense
F-560 or R-602 RNAs, respectively.
A quantitative analysis of an experiment with
different time points is shown on the left.
Data were normalized for the recovery
of promoterless R-luc or F-luc plasmids
co-injected with mRNAs (not shown).
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Although these results support the idea that new RNA
synthesis is not required for RNAi activity in vivo, it is
possible that very small RNA molecules could be pro-
duced even in the presence of a chain-terminating sub-
strate. To obtain additional evidence as to whether
dsRNAs or their products act directly or indirectly, we
examined the strand dependence of the RNAi reaction.
The antisense strand of dsRNA determines RNAi specificity
If full-length dsRNA or processed 21–23 nt species target
mRNAs directly through base pairing, the sequence of the
antisense strand would be the critical determinant of
target specificity. If targeting is indirect, through produc-
tion of complementary antisense transcripts, the sense-
strand sequence of the dsRNA should determine specificity.
To test the relative importance of the two strands, we
compared the RNAi activity of dsRNAs when one or the
other of the strands contained mismatches with the target
mRNA. The F-luc reporter genes in the vectors pGL2 and
pGL3 differ in sequence because of optimization of codon
usage (Figure 1). Taking advantage of these base changes,
we made mismatched dsRNAs with one strand from GL2
and one from GL3 and measured their ability to inhibit
expression from a GL3 DNA template. In experiments
with a 152 bp dsRNA, the perfectly paired control
GL3–GL3 dsF-152 RNA caused a 33-fold inhibition of
F-luc expression (Figure 5b). When a sense GL2–anti-
sense GL3 dsRNA (9% mismatch) was used, there was a
potent, 17-fold inhibition. In contrast, the reversed sense
GL3–antisense GL2 dsRNA, which should pair poorly
with the GL3-derived mRNA, was incapable of mediating
a significant RNAi reaction (Figure 5b). To confirm that
these results reflected altered pairing properties of the
sense- and antisense-strand sequences rather than differ-
ential stability of the two mismatched dsRNAs, we modi-
fied the experiment so that the mRNA target was derived
from a GL2 template. In this case, we found that the
sense GL3–antisense GL2 dsRNA mediated a potent
RNAi reaction whereas the activity of the sense GL2–
antisense GL3 molecule was greatly impaired (Figure 5b).
Taken together, these results suggest that the antisense
strand is the determinant of target specificity, as predicted
by the direct interaction model.
In the experiment with the GL3 template, the perfectly
paired but mRNA mismatched GL2–GL2 dsRNA was
more active than was the imperfectly paired and mis-
matched GL3–GL2 dsRNA (Figure 5b). This could
reflect the added effects of imperfect pairing on dsRNA
processing and on hybridization to the target message. To
determine whether the mismatched dsRNAs were processed
less efficiently than the perfectly paired molecules, we
examined the production of 32P-labeled 21–23 nt RNAs
from the various dsF-152 templates. We found that,
within experimental error, 23 nt RNAs were produced
with similar efficiency from the mismatched and perfectly
paired templates (Figure 5c). An alternative explanation
for the reduced activity of mispaired and mismatched
dsRNAs could be that mispairing affects a step between
dsRNA processing and mRNA target recognition by the
antisense strand. If so, this would suggest that the
21–23mer species may remain base-paired after process-
ing. In support of this, we found that purified 21–23 nt
RNAs produced from GL2–GL2 and GL3–GL3 tem-
plates were partially resistant to RNase A or T1 digestion,
suggesting they may be double stranded (Figure 5c and
data not shown.) The 21–23mers produced from mis-
matched templates were, however, sensitive to RNase
digestion, suggesting that they were single stranded or
sensitive to denaturation under our experimental condi-
tions (data not shown). Although these results hint that
the processed 21–23 nt RNAs may be base-paired in vivo,
we cannot rule out the possibility that the 21–23 bp
species formed in vitro after isolation of the RNA samples.
RNAi can be inhibited by excess unrelated dsRNA
If the initial step in RNAi is the processing of a dsRNA to
21–23 nt guide RNAs, the activation event is likely to be
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Figure 4
Double-stranded RNA is rapidly processed into 21–23 nt species
in vivo. dsR-800 RNAs, uniformly labeled with 32P on either the sense
or antisense strand, were injected into embryos, and RNA was
sampled at the indicated times thereafter. For each time point, 20
embryos were collected and quick frozen before RNA extraction. Lanes
marked 0 contain uninjected samples. Samples were electrophoresed
on 6% denaturing polyacrylamide gels. M, 32P-labeled 10 bp DNA
ladder (Gibco-BRL).
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mediated by a non-specific dsRNA binding/cleavage
activity. If so, it should be possible to inhibit the RNAi
reaction by adding excess unrelated dsRNA. To test this,
we injected double-stranded R-luc RNAs along with a
40-fold excess of unrelated dsRNA and assayed relative
R-Luc expression from plasmid templates. We found that
excess R-137i, Sxl and lacZ dsRNAs were effective
inhibitors of the RNAi activity of the dsR-80 and dsR-145
molecules, as was the artificial polymer polyI–polyC
(Figure 6a, and data not shown). Because there are no lacZ
or polyI–polyC ssRNA targets in the embryos, the dsRNA
competitors must interfere with a step before ssRNA target
recognition. To further characterize the non-specific dsRNA-
binding activity, we studied the concentration dependence
of the dsRNA competition reaction using short, 60 bp, and
long, 1200 bp, lacZ dsRNAs. We found that both the long
and short dsRNA competitors could completely inhibit the
RNAi reaction; however, it required approximately 150 times
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Double-stranded RNA interacts directly with its mRNA target. (a) New
RNA synthesis is not required for RNAi. Samples (dsRNA and mRNA)
were injected sequentially (left) or co-injected (right). Injection buffers
contained 0.4 µM dsR-602, 2.0 µM R-luc and 0.7 µM F-luc mRNA
(left), or 0.4 µM dsF-600 RNA, 2.0 µM F-luc and 2.0 µM R-luc mRNA
(right), with or without 38 mM 3′dATP as indicated. (b) The antisense
strand directs target specificity. Effect of mismatched strands on RNAi;
dsF-152 RNA (0.6 µM), with the indicated sense and antisense strands
from pGL2 or pGL3, was used to inhibit expression from DNA
templates derived from pGL3 (left) or pGL2 (right). (c) Mismatched
dsRNA templates are processed to 21–23mer species. RNase
T1-treated dsF-152 RNAs with the indicated sense (32P) and antisense
strands from pGL2 (2) or pGL3 (3) were injected into embryos and
RNA samples taken 30 min later. For each dsRNA sample, 20 embryos
were quick frozen before RNA extraction. Extracted RNA samples were
either dissolved directly in loading buffer or treated with RNase A or T1
before electrophoresis on 8% denaturing polyacrylamide gels.
Unmarked lanes contained 32P-labeled 10 bp DNA ladder.
Figure 6
Excess unrelated dsRNA can inhibit RNAi.
(a) The injection buffer contained DNA
templates, dsR-80 or dsR-145 RNAs
(0.15 µM), and either dsR-137i RNA,
dsSxl-490 RNA (6 µM) or polyI–polyC
(2 µg/µl) as competitors. (b) Dose-response
to competitor dsRNA. The injection buffer
contained expression plasmids, dsR-291 RNA
(0.075 µM), and the indicated concentrations
of 60 bp or 1200 bp lacZ dsRNA as
competitor.
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more of the 60 bp RNA than of the 1200 bp RNA to
achieve a given degree of inhibition (Figure 6b). The
1200 bp RNA was even more effective than would be pre-
dicted based on its relative length alone. When corrected
for size, the 1200 bp molecule was still 7–8 times more
effective an inhibitor than was the 60 bp dsRNA.
Excess complementary sense and antisense RNAs can
inhibit RNAi
We have shown that the antisense strand of dsRNA deter-
mines mRNA target specificity (Figure 5b). This suggests
that the nucleases responsible for RNAi contain bound
antisense strands that base pair with complementary
mRNAs, thereby marking them for destruction [14,15,17].
If so, it should be possible to inhibit the nucleases by
adding an excess of complementary sense-strand RNA to
compete for mRNA binding. We examined three different
ssRNAs for their ability to block the action of dsR-291
RNA on R-luc expression. Two of these, snR-280 and
snR-605, were represented in dsR-291 RNA and comple-
mentary to R-luc mRNA, whereas the third, snR-300, was
represented in the mRNA but did not overlap with dsR-291
(Figure 1). We found that the sense-strand RNAs corre-
sponding to the dsRNA strongly inhibited the RNAi
reaction, but that the non-complementary snR-300 was
without effect (Figure 7a). 
If the targeting nucleases contain both strands of the
processed dsRNA, excess complementary antisense RNA
would also be predicted to inhibit the RNAi reaction.
However, because high concentrations of antisense RNA
inhibited luciferase expression on their own (Figure 2d
and data not shown), it was not possible to test this hypoth-
esis using the above protocol. Instead, we exploited the
base changes between the GL2 and GL3 F-luc genes to
create an antisense RNA that perfectly matched the RNA
in the nucleases, but which no longer paired efficiently with
the mRNA target, in effect, inhibiting the classical anti-
sense activity of the antisense strand without seriously
impairing its interactions with RNAi-specific molecules.
For the experiments shown in Figure 7b (left panel), we
used GL2–GL2 dsF-152 RNA to target degradation of
GL3-derived F-luc mRNA (9% mismatch). To measure the
effect of excess antisense strand, we used a smaller 106 nt
GL2 antisense RNA that perfectly matched the GL2
dsRNA, but which had a 13% mismatch with GL3 mRNA.
We found that GL2 asF-106 RNA alone had no effect on
GL3 F-luc expression (data not shown), suggesting that the
mismatches blocked the association of the two ssRNAs. In
contrast, the GL2–GL2 dsF-152 RNA caused an 11-fold
reduction in GL3 F-luc expression, showing that it pos-
sessed an easily measurable RNAi activity (Figure 7b, left
panel). Critically, when excess GL2 asF-106 RNA was co-
injected with dsF-152 RNA, it effectively prevented gene
silencing, demonstrating that excess antisense RNA can
inhibit the RNAi reaction (Figure 7b, left panel). 
We performed the reciprocal experiment using GL3–GL3
dsF-152 RNA to target degradation of GL2-derived F-luc
mRNA and found that excess GL3 asF-106 RNA also
appeared capable of inhibiting the RNAi reaction
(Figure 7b, right panel). This experiment included a
control demonstrating that excess unrelated single-strand
RNA had no effect on the reaction, as was seen in the
sense-strand competition experiments.
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Figure 7
Excess homologous single strands can inhibit
RNAi. (a) Competition with excess sense-
strand RNAs. The injection buffer contained
expression plasmids, plus or minus dsR-291
RNA (0.15 µM) and snR-300, snR-280 or
snR-605 ssRNAs (12 µM); snR-280 and
snR-605 overlap with dsR-291, snR-300
does not. (b) Competition with excess anti-
sense RNA. Left, R-luc and GL3-based F-luc
expression plasmids were injected, plus or
minus GL2 dsF-152 RNA (0.15 µM) and
GL2 asF-106 RNA (6 µM), 2.0 µm F-luc and
R-luc RNA. Right, buffer contained R-luc and
GL2-based F-luc plasmids, plus or minus
GL3 dsF-152 RNA (0.15 µM), lacZ (1200 bp)
sense-strand RNA (1 µM), or GL3 asF-106
RNA (6 µM). The large variation in samples
injected with the GL3 asF-106 RNA (right)
was primarily due to 5 (of 18) embryos that
did not respond to asF-106 RNA. For the
other 13 embryos, the mean F- to R-luc ratio
was 0.11 (± 0.067).
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Discussion
21–23 nucleotide RNAs
The involvement of processed small RNAs in RNAi
[14–16] is supported by our finding that processed 21–23 nt
RNAs appeared within ~10 minutes of dsRNA injection,
and that their levels were maintained throughout the period
when dsRNA exerted its inhibitory effects (Figure 4). The
rapid processing of dsRNA to the presumed active form is
consistent with the 10–30-fold decrease in cognate mRNA
levels observed within ~30 minutes of dsRNA injection
(Figure 3b), and with the potent inhibition of luc expression
in experiments where mRNA templates were co-injected
with dsRNAs (Figures 2c,5b). Because one-third of the total
Luc activity was produced within ~20 minutes of injection
in such co-injection experiments, the strong inhibition of luc
expression indicates that dsRNA can target injected mRNA
for degradation nearly as fast as it can be targeted for trans-
lation. At the other end of the spectrum, in experiments
with DNA templates, the vast majority of luciferase activity
appeared between 2 and 3 hours, coincident with the
period of high-level expression of the sisA and sisB promot-
ers [22] (data not shown). The presence of processed
21–23 nt RNAs 2–3 hours after injection is thus consistent
with their involvement in potent inhibition of luc gene
expression observed when DNA templates were used
(Figures 2,3a,6,7). Taken together, the temporal correlation
between dsRNA-induced gene silencing, and the appear-
ance and persistence of processed 21–23 nt RNAs, provides
strong correlative evidence that these small RNAs are the
active agents in vivo.
Substoichiometric action
It has been reported that one dsRNA molecule can inhibit
more than one target mRNA in C. elegans and Drosophila
[1,12]. Consistent with those findings, we observed full
RNAi activity when mRNA was present in a 10–25-fold
molar excess over the injected dsRNA (Figure 2e). Simi-
larly, a 5-fold lower amount of dsRNA induced a 10–30-
fold decrease in mRNA levels, suggesting that dsRNA
acted substoichiometrically to degrade mRNA in our assay
(Figure 3b). In theory, processing of dsRNAs into active
small RNAs could amplify the original gene-silencing
signal, making the concentration of 21–23mers equal to or
greater than that of the mRNA. However, analysis of
injected 32P-labeled dsRNA (Figures 4,5c), or of unla-
beled dsRNA by northern blot (data not shown), revealed
that injected dsRNA was relatively stable, indicating that
only a fraction of the dsRNA was converted to 21–23 base
species in our experiments. Interestingly, similar results
have been found in vitro, where ~15% of input dsRNA are
processed in a 2 hour reaction [15]. The incomplete con-
version implies that the dsRNA processing machinery is
likely to be limiting in the early embryo, an inference con-
sistent with both the saturability of the RNAi reaction
(Figure 2d,e) and the presumed maternal origin of its
protein components. Given that only a fraction of dsRNAs
was cleaved, dsRNA processing alone is unlikely to fully
explain the apparent substoichiometric inhibition by
dsRNA, making it likely that individual 21–23 nt RNAs
target multiple mRNAs for destruction. We have incorpo-
rated this idea into a model for the RNAi mechanism
(Figure 8). The model builds on the in vitro results of
Hammond et al. [14] and Zamore et al. [15] and can
account for other known properties of RNAi, including its
direct action, specificity, size and strand dependence, and
sensitivity to dsRNA and ssRNA competitors.
RNAi without new RNA synthesis
An alternative explanation for the ability of dsRNA to act
substoichiometrically is that large dsRNAs, or smaller
processed products, could serve as templates for an RdRP,
and that the newly synthesized RNAs are the active
agents in RNAi. Despite genetic links of RdRPs to PTGS
in several species [18–21], our studies suggest that dsRNA
or its processed products can be sufficient to inhibit gene
expression without the involvement of new RNA synthe-
sis. Using dsRNAs with mismatched strands, we found
that the antisense strand of the dsRNA determines target
specificity, the result predicted if full-length or processed
dsRNAs directly base pair with the mRNA target, and one
contrary to expectations if the active antisense strands
arise through transcription of the original template
(Figure 5b). Direct interaction between dsRNA and the
mRNA target is also suggested by our observation that an
effective RNAi reaction can be mounted in the presence
of high concentrations of the RNA chain terminating sub-
strate cordycepin (Figure 5a). 
Although our studies strongly suggest that dsRNAs, or
their processed products, can directly mediate RNAi
in vivo, they do not imply that other aspects of PTGS are
independent of new RNA synthesis. In particular, we did
not address long-lived or heritable RNAi, where signal
amplification by RdRPs could explain persistent gene
silencing [9], nor did we address situations in which RdRPs
may amplify or create silencing signals from transgenes or
duplicated loci. In this regard, the finding that Arabidopsis
SDE1/SGS2 is required for silencing transgenes but dispens-
able for anti-viral PTGS responses [20] suggests that the
function of RdRPs may be superfluous when large amounts
of dsRNAs are introduced directly into cells.
Dependence of RNAi on the length of dsRNA
Numerous results indicate that long dsRNAs are more
effective in mediating RNAi than are short dsRNAs
[13,14,23,24]. One explanation is that processing of large
dsRNAs should generate a greater variety of 21–23 nt
RNAs than would similarly processed small dsRNAs. The
larger sequence set of 21–23 nt RNAs would thus be capable
of interacting with many more sites on target mRNAs,
increasing the chance that at least one RNA-containing
nuclease will pair with its target sequence and destroy an
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mRNA. Such a model would predict that RNAi efficiency is
a higher order function of dsRNA size, as the concentrations
of active fragments and potential target sites should both
increase with dsRNA length, a prediction consistent with
the log-linear relationship between dsRNA length and
RNAi activity shown in Figure 3a. From a practical stand-
point, these data offer quantitative support for previous
qualitative assessments that larger dsRNAs are more effec-
tive at RNAi, and suggest that one should use the largest
molecules practical when testing new dsRNAs.
Evidence for a dsRNA activation step
The findings that dsRNAs can be processed into 21–23 nt
RNAs ([15]; Figure 4), or small RNA-containing nucleases
[14], in the absence of cognate ssRNAs argues that dsRNA
molecules are activated by a process that does not require
interactions with their mRNA target. Activation would
appear to be a limiting step in RNAi, as the reaction is satu-
rated at relatively low levels of dsRNA in vivo (Figure 2d,e),
potentiated by long-term incubation with dsRNA in vitro
[23], and competed by excess unrelated dsRNAs in vivo and
in vitro ([23], and Figure 6). While the mechanism by which
excess unrelated dsRNA blocks RNAi is speculative, we
suspect that lacZ and Sxl dsRNAs compete at the level of
processing, and/or nuclease assembly (Figure 8), as both
dsRNAs can inhibit expression of their cognate genes in vivo
([14], and data not shown). The finding that a 60 bp lacZ
dsRNA was a disproportionately less effective competitor
than was a 1200 bp lacZ dsRNA (Figure 6b) may indicate
that large dsRNAs are more efficiently processed than very
small ones, allowing them to compete more effectively for
the limited pool of RNAi nuclease precursors.
Evidence for a two-stranded RNAi nuclease
The ability of excess sense-strand RNA to protect mRNA
from degradation suggests direct competition for base
pairing to the silencing agent (Figure 7a). Such competi-
tion should occur regardless of whether the RNAi nucle-
ases carry one or both dsRNA strands. On the other hand,
the ability of excess antisense strand to protect mRNAs
(Figure 7b), as well as the partial resistance of 21–23mers
to RNase treatment (Figure 5c), suggests that both strands
of the processed dsRNA are incorporated into individual
RNAi nucleases. The presence of both 21–23 nt strands in
the RNAi nuclease complex suggests that mRNA binding
must involve dissociation of the strands before, or in
concert with, mRNA binding ([17], and Figure 8).
Although excess ssRNA clearly can inhibit RNAi, its
ability to do so suggests additional complexities in the
substrate recognition and cleavage process. One means of
inhibition would be if the RNAi nuclease were irre-
versibly inhibited by interaction with ssRNAs. This would
explain why ssRNAs can protect newly synthesized
mRNAs from degradation up to 3 hours after injection
(Figure 7), but would complicate the issue of nuclease
recycling. A second possibility is competitive inhibition,
which would require that the ssRNAs compete for RNAi
nuclease binding over the entire course of the reaction.
Interestingly, we found that co-injected snR-291 RNA can
persist up to 3 hours after injection (data not shown),
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Figure 8
Model for RNAi. Double-stranded RNAs are bound and cleaved by a
dsRNA-specific nuclease to generate 21–23 bp products. The 21–23 nt
sense (black) and antisense (blue) strands are incorporated into a
multiprotein RNAi nuclease, perhaps coincident with processing. The
bound 21–23 nt antisense strand base pairs with an mRNA target (red).
Bound mRNAs undergo endonucleolytic cleavage at one or both
double strand–single strand junctions and the base-paired mRNA
segment is digested by an associated 3′–5′ exonuclease (gray),
perhaps corresponding to the C. elegans mut-7 gene product [8]. The
free RNAi nuclease recycles, allowing catalysis. Excess unrelated
dsRNAs, such as lacZ or Sxl, compete for the assembly of RNAi
nucleases, while excess polyI–polyC could compete by titrating the
dsRNA-binding activity (Figure 6). Excess sense and antisense strands
are competitive inhibitors of mRNA binding (Figure 7). When one bound
21–23mer is paired, the other is inaccessible. We have arbitrarily drawn
an associative mechanism whereby the mRNA invades the 21–23 bp
duplex [17], rather than a dissociative one in which the 21–23 nt strands
separate before interaction with mRNA. Similarly, our data are compatible
with nuclease regeneration through strand exchange between bound
21–23mers and mRNA [17]. Cap and poly(A) mark mRNA ends;
neither structure is required for RNAi ([14,15], and data not shown).
AAAA
AAAA
Cap
Cap
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suggesting that short ssRNAs may be cleaved less effi-
ciently than mRNAs. Curiously, a potentially related sub-
strate length dependence has been observed in vitro, as
extracts prepared from dsRNA-transfected cells efficiently
degrade > 600 nt ssRNAs, but show dramatically reduced
activity against shorter transcripts [14].
Regardless of these complications, competition by excess
sense and antisense strands suggests that individual RNAi
nucleases can target either RNA strand for degradation.
While of little apparent consequence for experiments in
which mRNA is the exclusive target, RNAi is likely to
reflect natural defenses against viruses and transposable
elements. As such, bifunctional nucleases could provide
an efficient defense against RNA viruses, as every nucle-
ase could act at each stage of the viral growth cycle.
Materials and methods
In vivo and in vitro RNA synthesis and preparation of dsRNA
The pGL2 and pGL3-derived F-luc expression plasmids carried the
sisA promoter. R-luc plasmids (pRL-null) carried the sisB promoter. In
vitro mRNA synthesis utilized PCR-derived templates containing a
5′ T7 promoter and 3′ poly(A) sequences. All non-radioactive tran-
scripts were produced in the presence of cap analog
m7G(5′)ppp(5′)G. For dsRNA, individual strands were synthesized
using phage RNA polymerases and PCR-derived templates carrying a
phage promoter at one end. To make dsRNA, equal amounts of sense
and asRNA were mixed, heated to 90°C, and reannealed over several
hours. Annealing was monitored by ethidium bromide staining of
agarose gels. All dsRNA had 18-base single-stranded overhangs
because of the template promoter sequences. 
Microinjection and luciferase assay of injected embryos
Embryos (0–1 h) were injected under oil according to standard proto-
cols. Needles were connected to a hand-operated air-filled syringe.
Approximately 0.1 nl was injected into the center of each embryo. For
sequential injections, dsRNA (or buffer) was injected first, followed by
mRNA 20 min later. After injection, embryos developed for 3 h at 25°C.
Single embryos were assayed using a dual-luciferase system (Promega).
Stability of mRNA and dsRNA
F-luc and R-luc mRNAs, ± cognate dsRNAs, were co-injected into
90–120 embryos. 30 embryos were pooled per time point and RNA
was isolated by guanidinium extraction. Five embryo equivalents of
RNA were loaded per lane and analyzed by northern hybridization. To
measure dsRNA processing, either sense or antisense strands of
dsR-928 or dsF-152 were internally 32P-labeled and mixed with unla-
beled complementary strand to make 32P-dsRNA. In some experiments
32P-dsRNAs were treated with RNase T1 (2.0 µg/ml) for 15 min at
22°C to eliminate ssRNA contaminants. Labeled dsRNAs were
injected and RNA samples prepared as described above except that
10 or 20 embryos were pooled per time point. Some purified RNA
samples were treated with RNases A (40 µg/ml) or T1 (3.0 µg/ml) for
1 h at 30°C before analysis.
Supplementary material
Supplementary material including full methodological detail is available
at http://current-biology.com/supmat/supmatin.htm.
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